Article | August 23, 2022

How To Improve Recruitment Rates, Reduce Site Burden, And Avoid Wasted Spending

Source: Trialbee AB

By Matt Walz, CEO, Trialbee


When Facebook banned ads that target patients based on “sensitive data” related to their health condition, it might have been easy to conclude that the social media giant would stifle drug development research as a result. While Facebook is just one example of social media used by clinical trials to recruit patients, we would estimate that Facebook accounts for roughly half of all direct-to-patient recruited participants for a given trial, based on our observations from running global patient recruitment campaigns in the past few years.

The truth, however, is that Facebook’s ban, which went into effect in January, is not a setback.

It’s an opportunity.


Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.

Subscribe to Clinical Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Clinical Leader